Chairman’s Opening Remarks

08:30 AM - 09:00 AM

Smart Pharma: Key Trends that are Transforming Drug Discovery and Development

This opening session will set the stage for the discussions that will take place over the course of the Summit and identify the key trends that are taking hold in biopharma and reshaping drug discovery and clinical development. Themes will include:

  • Reduced timelines and improved accuracy of prediction of safety and efficacy
  • Diversified drug pipelines with new targets and drug re-purposing
  • Challenges: data sharing, access to reliable, robust data, and establishing new standardization
  • The dynamics of the continually evolving partnership ecosystem – biopharma, technology platforms, CROs, investors, regulatory and patients.
Chair
Harry Glorikian, General Partner, New Ventures Funds
Author: MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market